![Brandon Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brandon Smith
Directeur des opérations chez
PROTHENA CORPORATION PLC
Fortune : 1 M $ au 31/05/2026
Profil
Brandon S.
Smith is Chief Operating Officer at Prothena Corp.
Plc since 2021.
Formerly, Mr. Smith was Chief Operating Officer at Iconic Therapeutics, Inc. from 2017 to 2020, Senior VP and VP-Corporate Development & Strategy at Impax Laboratories LLC from 2012 to 2017, and Executive Director-Biosimilars Strategy at Amgen, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Michigan and an MBA from McCombs School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROTHENA CORP. PLC 0,25 % | 03/03/2026 | 130 000 ( 0,25 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Brandon Smith
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Directeur des opérations | 29/09/2021 |
Anciens postes connus de Brandon Smith
| Sociétés | Poste | Fin |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Directeur des opérations | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Corporate Officer/Principal | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Brandon Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
McCombs School of Business
 McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
